NASDAQ: LPTX
Leap Therapeutics Inc Stock Ownership - Who owns Leap Therapeutics?

Insider buying vs selling

Have Leap Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James H. CavanaughDirector2024-11-13213$2.82
$600.66Buy
Augustine LawlorChief Operating Officer2024-11-132,136$2.82
$6.02kBuy
Christopher MirabelliChairman of the Board2024-11-132,136$2.82
$6.02kBuy
Douglas E. OnsiCEOCFOPres.GCTreas.Sec.2024-11-132,136$2.82
$6.02kBuy

1 of 1

LPTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LPTX insiders and whales buy or sell their stock.

LPTX Shareholders

What type of owners hold Leap Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC22.12%8,476,496$4.24MInsider
Beigene Ltd19.18%7,348,437$3.67MInsider
Gilead Sciences Inc13.88%5,319,148$2.66MInsider
Healthcare Ventures IX LP10.82%4,144,804$2.07MInsider
Balyasny Asset Management LP8.05%3,085,104$1.54MInstitution
John W. Littlechild6.83%2,618,406$1.31MInsider
Samsara Biocapital LLC6.37%2,442,352$1.22MInstitution
Augustine Lawlor4.45%1,703,751$851.88kInsider
Douglas E. Onsi3.94%1,510,471$755.24kInsider
Lilly Co Eli3.86%1,479,307$739.65kInsider

1 of 3

LPTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LPTX29.90%70.10%Net BuyingNet Buying
CARM12.47%74.05%
SNTI5.93%94.07%Net SellingNet Selling
SABS5.69%94.31%
INAB10.52%31.85%

Leap Therapeutics Stock Ownership FAQ

Who owns Leap Therapeutics?

Leap Therapeutics (NASDAQ: LPTX) is owned by 38.19% institutional shareholders, 89.55% Leap Therapeutics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Leap Therapeutics shareholder, owning 8.48M shares representing 22.12% of the company. Perceptive Advisors LLC's Leap Therapeutics shares are currently valued at $4.31M.

If you're new to stock investing, here's how to buy Leap Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.